Банкеръ Weekly



Sopharma has successfully sold its first private uncollateralized issue of 3-year corporate bonds of EUR5MN par value. Raiffeisenbank (Bulgaria) was the lead manager and underwriter. The securities have an annual, floating coupon, amounting to a 6-month EURIBOR plus 300 basic points, payable each...
Facebook logo
Бъдете с нас и във